Microsoft PowerPoint - 17 Introduction Valentini [Compatibil

Previous Page

Next Page

Page Background

Ongoing trials:

Other avenues currently being explored:

• immune checkpoint inhibitors:

03/01/13

PD-L1 and PD-1 (pembrolizumab and nivolumab)

• c-MET

• heat shock protein

• Hedgehog pathways.

• …